Physician profile
Christopher Campbell
NPI 1689037186
$12,754.46
in general payments reported to CMS, 2019-2025
29 companies · $1,188 in 2025
The $1,188 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $986 · 2022: $7,660 · 2023: $1,209 · 2024: $1,713 · 2025: $1,188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,045 · Travel and Lodging: $657 · Honoraria: $408.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,044.90 |
| Travel and Lodging | $656.58 |
| Honoraria | $407.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,000.00 | 2022 | |
| Boston Scientific Corporation | $2,185.58 | 2021-2025 | Lithovue, Ams 700, General - Erectile Dysfunction |
| Procept Biorobotics Corporation | $1,584.30 | 2021-2025 | Aquabeam System, Aquabeam Robotic System |
| Axonics, INC. | $641.41 | 2022-2024 | Axonics |
| Medtronic, INC. | $548.36 | 2021-2025 | Interstim |
| Agiliti Health, INC. | $300.16 | 2024-2025 | Sonablate Hifu, Koelis Trinity Mri/US Fusion, Siemens Healthineers Varian Cryocare |
| Coloplast Corp | $294.73 | 2022-2025 | Speedicath, Isiris Astent Removal Device |
| Endo Pharmaceuticals INC. | $171.58 | 2021-2024 | Xiaflex, Aveed |
| Teleflex LLC | $137.04 | 2023-2025 | Urolift, Barrigel |
| Abbvie INC. | $123.19 | 2022-2024 | Botox, Lupron Depot |
| Urogen Pharma, INC. | $84.88 | 2022-2025 | |
| Myovant Sciences INC. | $84.60 | 2021-2022 | |
| Pfizer INC. | $78.87 | 2022-2025 | |
| Astellas Pharma US INC | $62.86 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $61.98 | 2021-2024 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $60.64 | 2021-2022 | |
| Novo Nordisk INC | $51.32 | 2021-2024 | Rivfloza |
| Olympus America INC. | $38.32 | 2024-2025 | Itind System |
| Blue Earth Diagnostics | $35.97 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $34.64 | 2022 | |
| Myriad Genetic Laboratories, INC. | $32.82 | 2022-2023 | Prolaris |
| 180 Medical, INC. | $25.92 | 2025 | Gentlecath Glide |
| Kowa Pharmaceuticals America, INC. | $19.32 | 2023 | Seglentis |
| Ambu INC. | $17.16 | 2022 | |
| Alfasigma USA, INC. | $17.01 | 2021 | |
| Sumitomo Pharma America, INC. | $16.34 | 2023 | Orgovyx |
| Janssen Biotech, INC. | $15.56 | 2022 | |
| Laborie Medical Technologies Corp. | $15.25 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Recordati_rare_diseases_inc. | $14.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Campbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.